What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s (300255.SZ) StockRank?

MoatMap's StockRank for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) is 6/100, with a Strong Sell signal. This is a composite score combining Quality (27), Value (33), and Momentum (24) factor ranks across MoatMap's 20,000+ stock universe.

Does Hebei Changshan Biochemical Pharmaceutical Co., Ltd. have an economic moat?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. in?

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300255.SZ

STRONG SELLREMOVE

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. · Healthcare · China · $5.6B · Avg Vol: $82M/d

StockRank

P/E (TTM)

—

ROE

-27.0%

D/E

2.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Hebei Changshan Biochemical is primarily a generic heparin manufacturer facing intense price competition and lacks the high-barrier proprietary CDMO capabilities required to benefit from our pharma theme.

COMPANY DESCRIPTION

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. specializes in the research, production, and sale of heparin-based active pharmaceutical ingredients (APIs) and finished dosage forms, such as low molecular weight heparin injections. As a vertically integrated manufacturer, the company controls its supply chain from raw materials to finished products, ensuring high quality and cost advantages. It is a dominant player in China's heparin market and a major exporter to global pharmaceutical markets.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	345M	208M	152M	129M	-27.9%
EPS	0.00	-0.20	-0.04	-0.06	—
Shares	935M	919M	919M	919M	-1.7%
Debt	362M	344M	367M	373M	1.0%
Equity	452M	268M	231M	178M	-26.7%
Op CF	461,929	5M	8M	8M	161.2%
Inv CF	-64M	-35M	-35M	-18M	—
Fin CF	97M	-44M	27M	-9M	—

PRICE (1M)-43.8%

SMA 50SMA 200

$3.83

RSI (14)

20.6

52W High

$10.60

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-13.9%31.6

ROE

-27.0%27.0

GP/Assets

0.6%11.6

Op. Margin

9.6%64.9

FCF/Assets

7.7%80.5

Piotroski

—7.2

Int. Cover

-2.7x33.8

D/E Ratio

1.99x5.7

Current Ratio

0.74x4.3

Value

P/E (TTM)

—N/A

EV/EBITDA

-204.1x98.2

P/FCF

771.5x13.0

P/B

23.2x3.9

P/S

32.2x12.4

Div Yield

—N/A

Momentum

52W High %

36%9.8

RS 6M

-69%14.6

SMA 50/200

0.82x15.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

55%78.3

FUNDAMENTALS

Market Cap

$5.6B

P/E (Forward)

—

Gross Margin

2.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300255.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300255.SZ	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(you)	$5.6B	6	STRONG SELL
688796.SS	BIOCYTOGEN PHARMACEUTICALS (BEI	$7.2B	13	STRONG SELL
688166.SS	BrightGene Bio-Medical Technology Co., Ltd.	$3.3B	11	STRONG SELL
688520.SS	Sinocelltech Group Limited	$2.7B	8	STRONG SELL
603392.SS	Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	$6.5B	22	SELL
7666.HK	METIS TECHBIO-P	$2.2B	7	STRONG SELL
688180.SS	Shanghai Junshi Biosciences Co., Ltd.	$5.2B	25	SELL
9606.HK	Duality Biotherapeutics, Inc.	$2.6B	11	STRONG SELL
300122.SZ	Chongqing Zhifei Biological Products Co., Ltd.	$4.8B	25	SELL
688062.SS	Mabwell (Shanghai) Bioscience Co., Ltd.	$2.0B	3	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) — Stock Score Summary

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) has a MoatMap StockRank of 6/100 based on Quality (27/100), Value (33/100), and Momentum (24/100) factor scores. The current signal is STRONG SELL. Hebei Changshan Biochemical is primarily a generic heparin manufacturer facing intense price competition and lacks the high-barrier proprietary CDMO capabilities required to benefit from our pharma theme.

Key Financial Metrics

Price	$3.83
Market Cap	$5.6B
Price/Book	23.23
Return on Equity	-27.0%
Return on Invested Capital	-13.9%
Debt/Equity	199.18
Gross Margin	2.8%
Operating Margin	9.6%
Revenue Growth	-1.0%
Free Cash Flow	$7M

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.’s (300255.SZ) StockRank?: MoatMap’s StockRank for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) is 6/100, with a Strong Sell signal. It is a composite of Quality (27), Value (33), and Momentum (24) factor ranks across MoatMap’s 20,000+ stock universe.
Does Hebei Changshan Biochemical Pharmaceutical Co., Ltd. have an economic moat?: Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) is Strong Sell, based on a StockRank of 6/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. in?: Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).